Nexium Study To Suppress Nausea During Chemotherapy

NCT00206440 ↗

Phase 3 Terminated 43 enrolled Baylor Breast Care Center AstraZeneca · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will look at a drug called esomeprazole, the newest PPI, as a way to further reduce the amount of nausea and vomiting seen in breast cancer patients receiving adriamycin or epirubicin chemotherapy. Esomeprazole may help protect the gut lining from the stomach acid and thus lessen the nausea and vomiting. If patients have less stomach sickness, they may be able to enjoy their daily routines much more while they are getting chemotherapy.

Timeline

Start: 2005-08
Primary completion: 2009-02
Completion: 2012-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Esomeprazole	Small molecule	—	—

Indications

No indication recorded.